| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5813236 | Neuropharmacology | 2016 | 11 Pages |
Abstract
In conclusion, a 2-week oral treatment with varenicline prevented memory impairment in the scopolamine mouse model. In parallel, protein, but not mRNA expression was upregulated, suggesting a posttranscriptional mechanism. Our findings suggest a beneficial effect of varenicline on cognitive dysfunction.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Christian Lange-Asschenfeldt, Sandra Schäble, Tatsiana Suvorava, Ehsan Gholamreza Fahimi, Marion Bisha, Torben Stermann, Uwe Henning, Georg Kojda,